In mice with DOX‐inducible PRKCQ‐AS1 shRNA‐1 SK‐N‐AS cell xenografts, tumor shrank from the third day after DOX treatment and completely regressed in 8 out of 12 mice with the longest tumor‐free days of 41 days. This evidence concerns the gene PRKCQ and neoplasm.